What are Mission Vision & Core Values of Gerresheimer Company?

The mission statement highlights innovation as a central tenet. Gerresheimer consistently invests in research and development to create advanced packaging and drug delivery systems. This commitment is evident in their expanding portfolio of ready-to-fill syringes and vials, catering to the growing demand for injectable medications.

The "deliver for a better life" aspect emphasizes the impact of Gerresheimer's products on patient health and well-being. Their solutions directly support the safe and effective administration of pharmaceuticals, contributing to improved healthcare outcomes globally. This is particularly relevant in the context of biologics and complex drugs, where precise delivery is crucial.

Gerresheimer's mission is primarily focused on the pharmaceutical, biotech, and cosmetics industries. These sectors are the primary beneficiaries of their packaging and drug delivery solutions. The company's strategic focus on these areas is reflected in its investments and product development efforts.

Gerresheimer operates on a global scale, with production sites and a customer base spanning Europe, the Americas, and Asia. This global reach allows them to serve a diverse range of clients and address the varying needs of different markets. Their international presence is key to their strategic objectives.

The unique value proposition of Gerresheimer lies in its role as an innovative systems and solutions provider. They focus on the safe and reliable delivery of drugs. This commitment to quality and safety is paramount in the pharmaceutical industry, and it underpins their mission.

The mission reflects a customer-centric approach, with a strong emphasis on understanding and meeting customer needs. This is evident in their development of customized solutions and their responsiveness to market demands. This approach is a key driver of their Gerresheimer strategy.

Gerresheimer aspires to be the market leader in health and well-being solutions. This involves a commitment to innovation and a focus on providing comprehensive delivery systems. The strategic direction indicates a move beyond traditional packaging to encompass advanced solutions.

The company's strategy emphasizes high-value solutions, biologics, and digital health. Investments in expanding capacity and acquisitions, such as Bormioli Pharma, support this focus. These areas are critical for achieving the Gerresheimer goals of market leadership.

Given Gerresheimer's current market position and strategic investments, the vision is both realistic and aspirational. The company already holds leading positions in key areas. This provides a solid foundation for future growth and expansion.

The acquisition of Bormioli Pharma significantly strengthens Gerresheimer's market position. This expansion of its portfolio supports its ambition to be a leading system and solution provider. This strategic move is crucial for achieving its Gerresheimer vision.

Gerresheimer aims to disrupt the industry through innovative solutions. This involves moving beyond traditional packaging to encompass comprehensive delivery systems and digital health solutions. This approach will help the Gerresheimer company to stand out.

Gerresheimer's current market position in areas like plastic packaging and inhalers is strong. The company's strategic focus and investments are designed to drive further growth and solidify its leadership in the market. To understand the Gerresheimer strategy better, you can read about it.

Gerresheimer is actively shifting its portfolio towards high-margin products, such as ready-to-fill syringes, cartridges, pens, and auto-injectors. This strategic move directly supports the Gerresheimer mission by focusing on solutions that improve patient outcomes and well-being. This shift is evident in the impressive 8.0% organic revenue growth experienced by the Plastics & Devices division in fiscal year 2024.

Recognizing the growth of the biologics market, Gerresheimer is investing heavily in expanding its production capabilities for containment solutions and drug delivery systems. This strategic investment supports the Gerresheimer goals by enabling the company to supply essential packaging and devices for innovative drugs, particularly biopharmaceuticals, which represent approximately 90% of the global drug pipeline. This expansion is crucial for maintaining a competitive edge and contributing to advancements in healthcare.

The acquisition of Bormioli Pharma significantly enhanced Gerresheimer's product portfolio, especially in plastic and glass packaging. This move aligns with the Gerresheimer vision of becoming a leading global partner for health and well-being delivery solutions by offering a more comprehensive range of products and services. The integration is expected to boost revenues and adjusted EBITDA from 2025, demonstrating the long-term strategic benefits of this acquisition.

CEO Dietmar Siemssen emphasizes customer centricity, innovation, and operational excellence as key drivers of Gerresheimer's strategy. These principles, underpinned by the Gerresheimer core values, are essential for achieving sustainable growth. The company's focus on these areas ensures that it meets the evolving needs of its customers while maintaining a strong market position. Gerresheimer’s commitment to these values is further illustrated in Revenue Streams & Business Model of Gerresheimer.

Gerresheimer's sustainability strategy is a fundamental component of its corporate strategy, reflecting its commitment to a better life and well-being for future generations. This commitment is aligned with the Gerresheimer mission and vision, ensuring that the company operates responsibly and contributes positively to society. This includes initiatives aimed at reducing environmental impact and promoting sustainable practices throughout its operations.

The strategic decisions discussed above demonstrate how Gerresheimer's mission and vision shape its long-term planning and resource allocation. By prioritizing high-value solutions, expanding production capacities, and making strategic acquisitions, the company is investing in its future and positioning itself for continued success in the healthcare industry. The focus on innovation and customer needs ensures that Gerresheimer remains at the forefront of the market.

Gerresheimer is actively investing in expanding its production capabilities for high-value solutions, such as ready-to-fill syringes and medical devices. These investments are strategically focused on key regions like the US, Mexico, and Europe, reflecting a commitment to meeting growing market demands and solidifying its position as a leading provider of healthcare packaging solutions. For example, in 2023, Gerresheimer invested approximately €150 million in capital expenditures, with a significant portion allocated to expanding production capacities for high-value solutions. This directly supports the Gerresheimer mission to deliver innovative solutions and the Gerresheimer vision of leading in delivery solutions.

Gerresheimer's foray into digital health solutions demonstrates its dedication to innovation and improving patient outcomes. This includes the development of connected devices and digital platforms for therapy support, moving beyond traditional packaging to offer integrated solutions. This strategic move aligns with the Gerresheimer vision of being a comprehensive solutions provider in the healthcare sector. The company has been increasing its R&D spending in recent years, with a focus on digital health initiatives, showcasing its commitment to innovation. This commitment is further detailed in the Growth Strategy of Gerresheimer article.

Gerresheimer's sustainability strategy, encompassing programs like GxPure, GxCircular, and GxCare, showcases its commitment to environmental responsibility and a better future. These initiatives involve various measures, including reducing carbon emissions, promoting circular economy principles, and ensuring ethical sourcing of materials. For instance, the company is investing in hybrid furnace technology for glass production to reduce its environmental impact. Gerresheimer aims to reduce its Scope 1 and 2 greenhouse gas emissions by 46% by 2030 compared to the 2019 baseline, demonstrating a tangible commitment to sustainability. This directly reflects the Gerresheimer core values of responsibility and a commitment to future generations.

Leadership plays a crucial role in reinforcing the Gerresheimer mission, Gerresheimer vision, and Gerresheimer core values. CEO Dietmar Siemssen consistently emphasizes customer centricity, innovation, and operational excellence as key drivers of the company's strategy. The integration of acquisitions, such as Bormioli Pharma, is another area where leadership actively works to align the combined entity with Gerresheimer's established principles, leveraging the expanded portfolio for new integrated solutions. Communication of the Gerresheimer mission and Gerresheimer vision occurs through various channels, including the company website, investor relations materials, and corporate reports. The Gerresheimer core values are embedded in the Code of Conduct, guiding employee actions and decisions worldwide.